Adoptive cellular therapy

Current Topics in Microbiology and Immunology

Volumn 344, Issue 1, 2010, Pages 149-172

  Grupp, Stephan A ^a,b   June, Carl H ^b,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B7 ANTIGEN; CD28 ANTIGEN; CHIMERIC ANTIGEN RECEPTOR; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INTERLEUKIN 17; INTERLEUKIN 23; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICROSPHERE; PNEUMOCOCCUS VACCINE; TUMOR VACCINE; UNCLASSIFIED DRUG;

ADOPTIVE CELL THERAPY; ADOPTIVE IMMUNOTHERAPY; ADVERSE OUTCOME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARTIFICIAL ANTIGEN PRESENTING CELL; CANCER IMMUNIZATION; CANCER REGRESSION; CANCER RISK; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ENGINEERING; CELL THERAPY; CLINICAL EFFECTIVENESS; CULTURE TECHNIQUE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; GAMMA DELTA T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MELANOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; NONHUMAN; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; THERAPY EFFECT; TRANSGENICS; TUMOR IMMUNITY; VIRUS INFECTION; ANIMAL; BLOOD DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; NEOPLASM; REVIEW; T LYMPHOCYTE;

ANIMALS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; NEOPLASMS; NEUROBLASTOMA; T-LYMPHOCYTES;

EID: 79951481136     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-94     Document Type: Article

References (121)

1. Avigan D, Pirofski L, Lazarus H (2001) Vaccination against infectious disease following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7:171-183 (Pubitemid 32294216)
2. Azuma M, Phillips JH, Lanier LL (1993) CD28-T lymphocytes. Antigenic and functional properties. J Immunol 150:1147-1159 (Pubitemid 23127405)
3. Barber DL, Wherry EJ, Ahmed R (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 171:27-31 (Pubitemid 36745269)
4. Barrett J, Jiang YZ (2000) Allogeneic immunotherapy for malignant diseases. Marcel Dekker, New York
5. Bataille R, Jourdan M, Zhang X, Klein B (1989) Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 84:2008-2011 (Pubitemid 20016211)
6. Berger C, Turtle CJ, Jensen MC, Riddell SR (2009) Adoptive transfer of virus-specific and tumorspecific T cell immunity. Curr Opin Immunol 21:224-232
7. Bondanza A, Valtolina V, Magnani Z, Ponzoni M, Fleischhauer K, Bonyhadi M, Traversari C, Sanvito F, Toma S, Radrizzani M, La Seta-Catamancio S, Ciceri F, Bordignon C, Bonini C (2006) Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107:1828-1836 (Pubitemid 43289360)
8. Boulter JM, Glick M, Todorov PT, Baston E, Sami M, Rizkallah P, Jakobsen BK (2003) Stable, soluble T cell receptor molecules for crystallization and therapeutics. Protein Eng 16:707-711 (Pubitemid 37314399)
9. Brentjens R, Yeh R, Bernal Y, Riviere I, Sadelain M (2010) Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial. Mol Ther 18:666-668
10. Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan DF, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH (2009) Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci USA 106:3360-3365
11. Cheung NK, Kushner BH, Kramer K (2001) Monoclonal antibody-based therapy of neuroblastoma. Hematol Oncol Clin North Am 15:853-866 (Pubitemid 34026974)
12. Cheung NV, Heller G (1991) Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 9:1050-1058
13. Ciceri F, Bonini C, Stanghellini MTL, Bondanza A, Traversari C, Salomoni M, Turchetto L, Colombi S, Bernardi M, Peccatori J (2009) Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. Lancet Oncol 10:489-500
14. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH (2007) Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 67:9518-9527 (Pubitemid 47535942)
15. Clemente C, Mihm MJr., Bufalino R, Zurrida S, Collini P, Cascinelli N (1998) Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303-1310
16. Cooper LJ, Kalos M, Lewinsohn DA, Riddell SR, Greenberg PD (2000) Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T cell receptor genes. J Virol 74:8207-8212 (Pubitemid 30641669)
17. Curiel T (2007) Tregs and rethinking cancer immunotherapy. J Clin Invest 117:1167-1174 (Pubitemid 46718401)
18. de Visser K, Eichten A, Coussens L (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37 (Pubitemid 43053650)
19. Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Kwok S, June CH, Lazar R, Broad DF, Jalali S, Hege KM (2002) A phase II randomized study of HIV-specific T cell gene therapy in subjects with undetectable plasma viremia on combination anti-retroviral therapy. Mol Ther 5:788-797 (Pubitemid 34619072)
20. Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, Reisfeld RA, Theofilopoulos AN (2002) T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest 110:185-192 (Pubitemid 34787355)
21. EdingerM, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9:1144-1150 (Pubitemid 37173698)
22. Ege H, Gertz MA, Markovic SN, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Porrata LF (2008) Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Haematol 141:792-798 (Pubitemid 351724861)
23. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD (1999) The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11:173-181 (Pubitemid 29428810)
24. Fearon DT, Manders P, Wagner SD (2001) Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293:248-250 (Pubitemid 32694731)
25. FowlerDH,OdomJ, Steinberg SM,ChowCK, Foley J,KoganY,Hou J,Gea-Banacloche J, Sportes C, Pavletic S, Leitman S, Read EJ, Carter C, Kolstad A, Fox R, Beatty GL, Vonderheide RH, Levine BL, June CH, Gress RE, Bishop MR (2006) Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 12:1150-1160 (Pubitemid 44660857)
26. George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L (2006) High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 24:2891-2896 (Pubitemid 46630591)
27. Golovina TN,Mikheeva T, SuhoskiMM, Aqui NA, Tai VC, Shan X, Liu R, Balcarcel RR, Fisher N, Levine BL, Carroll RC, Warner N, Blazar BR, June CH, Riley JL (2008) CD28 costimulation is essential for human T regulatory expansion and function. J Immunol 181:2855-2868
28. Gross G, Waks T, Eshhar Z (1989) Expression of immunoglobulin-T cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci USA 86:10024-10028 (Pubitemid 20030768)
29. Grupp SA, Stern JW, Bunin N, Nancarrow C, Adams R, Gorlin JB, Griffin G, Diller L (2000a) Rapid-sequence tandem transplant for children with high-risk neuroblastoma. Med Pediatr Oncol 35:696-700
30. Grupp SA, Stern JW, Bunin N, Nancarrow C, Ross AA, Mogul M, Adams R, Grier HE, Gorlin JB, Shamberger R, Marcus K, Neuberg D, Weinstein HJ, Diller L (2000b) Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 18:2567-2575 (Pubitemid 30432523)
31. Guimond M, Veenstra R, Grindler D, Zhang H, Cui Y, Murphy R, Kim S, Na R, Hennighausen L, Kurtulus S (2009) Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol 10:149-157
32. Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A,Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, Macintyre E, Dal CL, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M (2008)Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J ClinInvest 118:3132-3142
33. Hakim F, Cepeda R, Kaimei S, Mackall C, McAtee N, Zujewski J, Cowan K, Gress R (1997)Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:3789-3798 (Pubitemid 27473453)
34. Hamza N, LisgarisM, Yadavalli G, Nadeau L, Fox R, Fu P, Lazarus H, Koc O, Salata R, LaughlinM (2004) Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 124:488-498 (Pubitemid 38230595)
35. Hasan A, Kollen W, Trivedi D, Selvakumar A, Dupont B, Sadelain M, O'Reilly R (2009) A panel of artificial APCs Expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy. J Immunol 183:2837-2850
36. Hinrichs C, Kaiser A, Paulos C, Cassard L, Sanchez-Perez L, Heemskerk B, Wrzesinski C, Borman Z, Muranski P, Restifo N (2009) Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 114:596-599
37. Hirano N, Butler MO, Xia Z, Ansen S, von Bergwelt-Baildon MS, Neuberg D, Freeman GJ, Nadler LM (2006) Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood 107:1528-1536 (Pubitemid 43242391)
38. Hoyle C, Goldman JM (1994) Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 14:247-252 (Pubitemid 24262548)
39. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP (2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852-856 (Pubitemid 36254145)
40. Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, Kammula US, Royal RE, Sherry RM, Wunderlich JR, Lee CC, Restifo NP, Schwarz SL, Cogdill AP, Bishop RJ, Kim H, Brewer CC, Rudy SF, Vanwaes C, Davis JL, Mathur A, Ripley RT, Nathan DA, Laurencot CM, Rosenberg SA (2009) Gene therapy with human and mouse T cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114:535-546
41. June CH (2007) Principles of adoptive T cell cancer therapy. J Clin Invest 117:1204-1212 (Pubitemid 46718405)
42. June CH, Blazar BR, Riley JL (2009) Engineering lymphocyte subsets: tools, trials and tribulations. Nat Rev Immunol 9:704-716
43. Kaech SM, Ahmed R (2001) Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2:415-422 (Pubitemid 33706139)
44. Kalamasz D, Long SA, Taniguchi R, Buckner JH, Berenson RJ, Bonyhadi M (2004) Optimization of human T cell expansion exvivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies. J Immunother 27:405-418 (Pubitemid 39121930)
45. Kim JV, Latouche JB, Riviere I, Sadelain M (2004) The ABCs of artificial antigen presentation. Nat Biotechnol 22:403-410 (Pubitemid 38451370)
46. King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265-277 (Pubitemid 38496245)
47. Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL (2002) Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stemcell rescue: results of the Chicago Pilot II Study. J Clin Oncol 20:2284-2292 (Pubitemid 34441655)
48. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517
49. Kroon F, van Dissel J, de Jong J, van Furth R (1994) Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. Aids 8:469-476 (Pubitemid 24102296)
50. Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling T (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141-1149
51. Lamers CH, Sleijfer S, Vulto AG, Kruit WH, Kliffen M, Debets R, Gratama JW, Stoter G, Oosterwijk E (2006) Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. J Clin Oncol 24:e20-e22
52. Landmeier S, Altvater B, Pscherer S, Eing BR, Kuehn J, Rooney CM, Juergens H, Rossig C (2007) Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function. Cancer Res 67:8335-8343 (Pubitemid 47395172)
53. Langowski JL, Zhang XQ, Wu LL, Mattson JD, Chen TY, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M (2006) IL-23 promotes tumour incidence and growth. Nature 442:461-465 (Pubitemid 44264796)
54. Lanzavecchia A, Sallusto F (2005) Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 17:326-332 (Pubitemid 40692670)
55. Laport GG, Levine BL, Stadtmauer EA, Schuster SJ, Luger SM, Grupp S, Bunin N, Strobl FJ, Cotte J, Zheng Z, Gregson B, Rivers P, Vonderheide RH, Liebowitz DN, Porter DL, June CH (2003) Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin's lymphoma following CD34-selected hematopoietic cell transplantation. Blood 102:2004-2013 (Pubitemid 37122373)
56. Latouche JB, Sadelain M (2000) Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nat Biotechnol 18:405-409 (Pubitemid 30217527)
57. Lerner B (2004) Sins of omission-cancer research without informed consent. N Engl J Med 351:628
58. Levine B, Bernstein W, Connors M, Craighead N, Lindsten T, Thompson C, June C (1997) Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol 159:5921-5930 (Pubitemid 127471527)
59. Levine BL, Ueda Y, Craighead N, Huang ML, June CH (1995) CD28 ligands CD80 (B7-1) and CD86 (B&-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro. Int Immunol 7:891-904
60. Lin W, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183 (Pubitemid 46718402)
61. Lone YC, Motta I, Mottez E, Guilloux Y, Lim A, Demay F, Levraud JP, Kourilsky P, Abastado JP (1998) In vitro induction of specific cytotoxic T lymphocytes using recombinant single-chain MHC class I/peptide complexes. J Immunother 21:283-294 (Pubitemid 28328408)
62. Luxembourg AT, Borrow P, Teyton L, Brunmark AB, Peterson PA, Jackson MR (1998) Biomagnetic isolation of antigen-specific CD8+ T cells usable in immunotherapy. Nat Biotechnol 16:281-285 (Pubitemid 28120109)
63. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Magrath IT, Wexler LH, Dimitrov DS, Gress RE (1997) Distinctions between CD8+ and CD4+ T cell regenerative pathways result in prolonged T cell subset imbalance after intensive chemotherapy. Blood 89:3700-3707 (Pubitemid 27227093)
64. Maher J, Brentjens RJ, Gunset G, Riviere I, Sadelain M (2002) Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor. Nat Biotechnol 20:70-75 (Pubitemid 34044918)
65. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106-2120 (Pubitemid 46935947)
66. Martin-Orozco N, Muranski P, Chung Y, Yang X, Yamazaki T, Lu S, Hwu P, Restifo N, Overwijk W, Dong C (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31:787-798
67. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer group. N Engl J Med 341:1165-1173 (Pubitemid 29480654)
68. Maus MV, Kovacs B, Kwok WW, Nepom GT, Schlienger K, Riley JL, Allman D, Finkel TH, June CH (2004) Extensive replicative capacity of human central memory T cells. J Immunol 172:6675-6683 (Pubitemid 38669103)
69. Maus MV, Thomas AK, Leonard DG, Allman D, Addya K, Schlienger K, Riley JL, June CH (2002) Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T cell receptor, CD28 and 4-1BB. Nat Biotechnol 20:143-148 (Pubitemid 34158029)
70. Milone MC, Fish JD, Carpenito C, Carroll RG, Binder GK, Teachey D, Samanta M, Lakhal M, Gloss B, net-Desnoyers G, Campana D, Riley JL, Grupp G, June CH (2009) Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther 17:1453-1464
71. Mitchison NA (1955) Studies on the immunological response to foreign tumor transplants in the mouse I. The role of lymph node cells in conferring immunity by adoptive transfer. J Exp Med 102:157-177
72. Molrine D, Guinan E, Antin J, Parsons S, Weinstein H, Wheeler C, McGarigle C, Blanding P, Phillips N, Kinsella K (1996) Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 87:3012-3018 (Pubitemid 26102254)
73. Morgan R, Yang J, Kitano M, Dudley M, Laurencot C, Rosenberg S (2010) Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther 18:843-851
74. Mueller M, Fusenig N (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839-849 (Pubitemid 39472951)
75. Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, Paulos CM, Palmer DC, Touloukian CE, Ptak K (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112:362-373
76. MuulLM, TuschongLM, Soenen SL, Jagadeesh GJ,RamseyWJ, Long Z, Carter CS,Garabedian EK, Alleyne M, Brown M, Bernstein W, Schurman SH, Fleisher TA, Leitman SF, Dunbar CE, Blaese RM, Candotti F (2003) Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial. Blood 101:2563-2569 (Pubitemid 36857614)
77. Nguyen P, Moisini I, Geiger T (2003) Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T cell receptor expression and function. Blood 102:4320
78. Oelke M, Maus MV, Didiano D, June CH, Mackensen A, Schneck JP (2003) Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig coated artificial antigen presenting cells. Nat Med 9:619-625
79. Park JR, Digiusto DL, Slovak M, Wright C, Naranjo A, Wagner J, Meechoovet HB, Bautista C, Chang WC, Ostberg JR, Jensen MC (2007) Adoptive transfer of chimeric antigen receptor redirected cytolytic T lymphocyte clones in patients with neuroblastoma. Mol Ther 15:825-833 (Pubitemid 46432004)
80. Porrata LF, GertzMA, Inwards DJ, Litzow MR, LacyMQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef IN, Geyer SM, Markovic SN (2001) Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 98:579-585
81. Porter DL, Levine BL, Bunin N, Stadtmauer EA, Luger SM, Goldstein S, Loren A, Phillips J, Nasta S, Perl A, Schuster S, Tsai D, Sohal A, Veloso E, Emerson SG, June CH (2006) A phase I trial of donor lymphocyte infusions expanded and activated ex-vivo via CD3/CD28 co-stimulation. Blood 107:1325-1331 (Pubitemid 43242365)
82. Powell JL, Bunin NJ, Callahan C, Aplenc R, Griffin G, Grupp SA (2004) An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma. Bone Marrow Transplant 33:651-657 (Pubitemid 38455929)
83. Pule MA, Straathof KC, Dotti G, Heslop HE, Rooney CM and Brenner MK (2005) A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol Ther 12:933-941 (Pubitemid 41614489)
84. Pule M, Savoldo B, Myers G, Rossig C, Russell H, Dotti G, Huls M, Liu E, Gee A, Mei Z (2008) Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med 14:1264-1270
85. Pulle G, Vidric M, Watts TH (2006) IL-15-dependent induction of 4-1BB promotes antigenindependent CD8 memory T cell survival. J Immunol 176:2739-2748
86. Rapoport A, Stadtmauer EA, Aqui N, Badros A, Cotte J, Chrisley L, Veloso EA, Zheng Z, Westphal S, Mair R, Chi N, Ratterree B, Pochran MF, Natt S, Hinkle J, Sickles C, Sohal A, Ruehle K, Lynch C, Zhang L, Porter DL, Luger S, Guo C, Fang HB, BlackwelderW, Hankey K, Mann D, Edelman R, Frasch C, Levine BL, Cross A, June CH (2005) Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T cell transfer. Nat Med 11:1230-1237 (Pubitemid 43093671)
87. Rapoport AP, Stadtmauer EA, Aqui N, Vogl D, Chew A, Fang HB, Janofsky S, Yager K, Veloso E, Zheng Z, Milliron T, Westphal S, Cotte J, Huynh H, Cannon A, Yanovich S, Akpek G, Tan M, Virts K, Ruehle K, Harris C, Philip S, Vonderheide RH, Levine BL, June CH (2009) Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of costimulated autologous T cells. Clin Cancer Res 15:4499-4507
88. Riddell SR, Greenberg PD (1990) The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 128:189-201 (Pubitemid 20120262)
89. Riley JL, June CH, Blazar BR (2009) Human T regulatory cell therapy: take a billion and call me in the morning. Immunity 30:656-665
90. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL (1990) Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323:570-578 (Pubitemid 20260084)
91. Rossig C, Bollard CM, Nuchtern JG, Merchant DA, Brenner MK (2001) Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T cell receptor genes. Int J Cancer 94:228-236 (Pubitemid 32911418)
92. Roux E, Helg C, Dumont-Girard F, Chapuis B, Jeannet M, Roosnek E (1996) Analysis of T cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T cell depleted and unmanipulated grafts. Blood 87:3984-3992 (Pubitemid 26129632)
93. Sadelain M, Brentjens R, Riviere I (2009) The promise and potential pitfalls of chimeric antigen receptors. Curr Opin Immunol 21:215-223
94. Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745-763 (Pubitemid 38680440)
95. Salomon B, Lenschow D, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone J (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440
96. Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler LM (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 100:2757-2765 (Pubitemid 28007544)
97. Schumacher TN (2002) T cell-receptor gene therapy. Nat Rev Immunol 2:512-519
98. Seder RA, Darrah PA, Roederer M (2008) T cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 211:58-66
99. Simon T, Hero B, Faldum A, Handgretinger R, Schrappe M, Niethammer D, Berthold F (2004) Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma. J Clin Oncol 22:3549-3557 (Pubitemid 41103661)
100. Southam CM, Brunschwig A, Levin AG, Dizon QS (1966) Effect of leukocytes on transplantability of human cancer. Cancer 19:1743-1753
101. Storek J, Dawson M, Lim L, Burman B, Stevens-Ayers T, Viganego F, Herremans M, Flowers M, Witherspoon R, Maloney D (2003) Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 33:337-346
102. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, Storb R, Appelbaum FR, Boeckh M (2001) Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97:3380-3389
103. Storek J, Zhao Z, Lin E, Berger T, McSweeney P, Nash R, Akatsuka Y, Metcalf M, Lu H, Kalina T (2004) Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clin Immunol 113:285-298 (Pubitemid 39422608)
104. Suhoski MM, Golovina T, Aqui NA, Tai VC, Varela R, MiloneMc CRG, Riley JL, June CH (2007) Engineering artificial antigen presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther 15:981-988 (Pubitemid 46621657)
105. Surh C, Sprent J (2008) Homeostasis of naive and memory T cells. Immunity 29:848-862
106. Taylor PA, Lees CJ, Blazar BR (2002) The infusion of ex vivo activated and expanded CD4(+) CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493-3499 (Pubitemid 34534513)
107. Thedrez A, Sabourin C, Gertner J, Devilder MC, lain-Maillet S, Fournie JJ, Scotet E, BonnevilleM (2007) Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? Immunol Rev 215:123-135 (Pubitemid 46212235)
108. Thomas ED (1999) Bone marrow transplantation: a review. Semin Hematol 36:95-103
109. Turtle C, Swanson H, Fujii N, Estey E, Riddell S (2009) A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity 31:834-844
110. van der Veeken LT, Coccoris M, Swart E, Falkenburg JH, Schumacher TN, Heemskerk MH (2009) Alpha beta T cell receptor transfer to gamma delta T cells generates functional effector cells without mixed TCR dimers in vivo. J Immunol 182:164-170
111. Varela-Rohena A, Molloy PE, Dunn SM, Li Y, Suhoski M, Carroll RG, Milicic A, Mahon T, Suttton DH, Laugel BE, Moysy R, Cameron BJ, Vuidepot A, Prubhoo ME, Cole DK, Philllps RE, June CH, Jakobsen BK, Sewell AK, Riley JL (2008) Control of HIV-1 immune escape by CD8 T cells expressing enhanced T cell receptor. Nat Med 14:1390-1395 [Epub 2008 Nov 1399]
112. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 300:1068-1073 (Pubitemid 9198740)
113. Weng NP (2006) Aging of the immune system: How much can the adaptive immune system adapt? Immunity 24:495-499
114. Weng NP, Levine BL, June CH, Hodes RJ (1997) Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J Immunol 158:3215-3220 (Pubitemid 127484036)
115. Woo EY, Chu CS, Goletz TJ, Schlienger K, Coukos G, Rubin SC, Kaiser LR, June CH (2001) Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non small cell lung cancer and late-stage ovarian cancer. Cancer Res 61:4766-4772 (Pubitemid 32691889)
116. Zhang H, Snyder K, Suhoski MM, Maus MV, Kapoor V, June CH, Mackall CL (2007) 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. J Immunol 179:4910-4918
117. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G,Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203-213 (Pubitemid 36077915)
118. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG (2005) Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med 11:1299-1305 (Pubitemid 41752910)
119. Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, Robbins PF (2005) Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 175:7046-7052 (Pubitemid 41598952)
120. Zhou L, Chong M, Littman D (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646-655
121. Zhu Y, Zhu G, Luo L, Flies AS, Chen L (2007) CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype. Blood 109:4882-4889 (Pubitemid 46827785)